Beneficial Effects of CpG-Oligodeoxynucleotide Treatment on Trauma and Secondary Lung Infection

Lorenz Wanke-Jellinek1, Joshua W Keegan2, James W Dolan2

  • 1Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115; Department of Trauma Surgery, Technical University of Munich, 81675 Munich, Germany;

Insights

CpG-oligodeoxynucleotide (ODN) treatment improved survival in mice with secondary Streptococcus pneumoniae lung infections after trauma. This immunotherapy modulated innate and adaptive immune cell responses, highlighting the role of T cell receptor gamma delta (TCRγδ) cells.

Area of Science:

  • Immunology
  • Microbiology
  • Trauma Research

Background:

  • * Streptococcus pneumoniae is a commensal but can cause severe infections like pneumonia and sepsis in trauma patients.
  • * Innate immune cell activation is a known response to sepsis following traumatic injury.
  • * Early-onset secondary lung infections pose a significant threat to trauma patient survival.

Purpose of the Study:

  • * To investigate the efficacy of A-class CpG-oligodeoxynucleotide (ODN) immunotherapy in improving survival after secondary S. pneumoniae lung infection in a mouse model of burn injury.
  • * To characterize the cellular immune response to infection and the impact of CpG-ODN treatment using mass cytometry and Luminex technologies.
  • * To elucidate the role of T cell receptor gamma delta (TCRγδ) cells in the immune response and immunotherapy effectiveness.

Main Methods:

  • * Establishment of a mouse model of burn injury followed by secondary S. pneumoniae lung infection.
  • * Administration of A-class CpG-ODN at 2 hours post-injury.
  • * Analysis of cellular immune responses using mass cytometry (cytometry by time-of-flight) and Luminex at 1 and 3 days post-infection.
  • * Assessment of cytokine levels in lung-washout samples from TCRγδ cell-depleted mice.

Main Results:

  • * CpG-ODN treatment significantly improved mouse survival.
  • * CpG-ODN reversed the upregulation of CD14, CD64, and PD-L1 on innate immune cells observed post-injury and infection.
  • * CpG-ODN treatment led to increased expression of CD25, CD27, MHCII, and IL-17 on TCRγδ cells and enhanced pathogen clearance.
  • * The beneficial effects of CpG-ODN on cytokine expression were dependent on functional TCRγδ cells.

Conclusions:

  • * A-class CpG-ODN immunotherapy is a promising strategy for improving outcomes in trauma patients with secondary S. pneumoniae lung infections.
  • * Cytometry by time-of-flight is effective for identifying cellular responses to trauma and infection and for discovering beneficial immunotherapy-induced immune phenotypes.
  • * Functional TCRγδ cells are critical mediators of the CpG-ODN immunotherapy's effects in this trauma-infection model.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.1K
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
871
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
739
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K